Biomarker A+T−: is this Alzheimer’s disease or not? A combined CSF and pathology study
Abstract The biological definition of Alzheimer’s disease using CSF biomarkers requires abnormal levels of both amyloid (A) and tau (T). However, biomarkers and corresponding cutoffs may not always reflect the presence or absence of pathology. Previous studies suggest that up to 32% of individuals w...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | 英语 |
出版: |
2022
|
在線閱讀: | https://doi.org/10.1093/brain/awac158 https://academic.oup.com/brain/article-pdf/146/3/1166/49356410/awac158.pdf |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|